According to the present invention, in the prior art,
staphylococcus aureus infection and
antibiotic resistance (AMR) are two important factors threatening
public health, such that persistent pain and even death may be caused, and the common health can be threatened by the
staphylococcus aureus infection and the
antibiotic resistance (AMR), such that the common health can be threatened by the
staphylococcus aureus infection and the
antibiotic resistance (AMR), and the common health can be threatened by the
staphylococcus aureus infection and the antibiotic resistance (AMR); therefore, it is urgent to develop alternative antibacterial materials. In the invention, a biocompatible nano
system (ZIF-67 HS) based on a hollow spherical
zeolite imidazate skeleton is successfully developed, and the biocompatible nano
system has a remarkable
bactericidal effect on
gram-positive
staphylococcus aureus in vitro and
in vivo. Importantly, the
research result shows that S. aureus does not generate secondary
drug resistance like traditional
antibiotics when being exposed to ZIF-67 HS with sub-
minimum inhibitory concentration for a long time; on the contrary, it maintains continuous sensitivity to antibiotic resistant strains. Multi-
omics analysis (including transcriptomics, metabonomics and metallomics) is combined with bioassays to prove that ZIF-67 HS destroys a plurality of necessary pathways in S.aures, including
amino acid metabolism, iron
metabolism,
membrane transport, ROS and S.aures infection pathways. According to the invention, a new insight is provided for the potential of nano biological medicines in the aspect of removing
bacteria, and a related
molecular mechanism is clarified.